Indo US Bio-Tech Ltd. - Research Center
541304 INDOUS Group (B) BSE data
Results
Statement
More
| Mar ' 25 |
Mar ' 24 |
Mar ' 23 |
Mar ' 22 |
Mar ' 21 |
Equity share capital
| 20.05 |
20.05 |
10.03 |
9.17 |
6.07 |
Share application money
Preference share capital
Reserves & surplus
| 58.47 |
42.70 |
44.47 |
29.71 |
15.47 |
Secured loans
| 14.84 |
14.32 |
11.60 |
9.11 |
7.19 |
Unsecured loans
Total
| 93.35 |
77.07 |
66.09 |
51.38 |
32.03 |
Gross block
| 14.53 |
6.69 |
7.37 |
5.54 |
2.33 |
Less : revaluation reserve
Less : accumulated depreciation
Net block
| 10.23 |
6.69 |
7.37 |
5.54 |
2.33 |
Capital work-in-progress
Investments
Current assets, loans & advances
| 87.61 |
73.99 |
60.73 |
47.70 |
39.35 |
Less : current liabilities & provisions
| 4.49 |
7.38 |
3.37 |
4.19 |
11.64 |
Total net current assets
| 83.12 |
66.60 |
57.36 |
43.51 |
27.70 |
Miscellaneous expenses not written
Total
| 93.35 |
77.07 |
66.09 |
51.38 |
32.03 |
Book value of unquoted investments
Market value of quoted investments
Contingent liabilities
Number of equity sharesoutstanding (Lacs)
| 200.52 |
200.52 |
100.26 |
91.67 |
60.68 |